Revision of Previously Issued Financial Statements (Tables)

3 Months Ended

Mar. 31, 2022

Accounting Changes And Error Corrections [Abstract]

Summary of Effect of Error on Each Financial Statement

The following tables summarize the effect of the error on each financial statement line item as of the dates, and for the periods, indicated.

	December 31, 2021
	As Previously Reported			Adjustments			As Revised
Balance Sheet (audited)
Common stock subject to redemption	$	115,000,000		$	2,875,000		$	117,875,000
Additional paid-in capital		475,848			(475,848	)		—
Accumulated deficit		(6,520,309	)		(2,399,152	)		(8,919,461	)
Total stockholders' deficit		(6,044,146	)		(2,875,000	)		(8,919,146	)

	September 30, 2021
	As Previously Reported			Adjustments			As Revised
Balance Sheet (unaudited)
Common stock subject to redemption	$	115,000,000		$	1,725,000		$	116,725,000
Accumulated deficit		(7,832,328	)		(1,725,000	)		(9,557,328	)
Total stockholders' deficit		(7,356,165	)		(1,725,000	)		(9,081,165	)

	June 30, 2021
	As Previously Reported in Amendment No. 1 of September 30, 2021 Form 10-Q			Adjustments			As Revised
Balance Sheet (unaudited)
Common stock subject to redemption	$	115,000,000		$	1,725,000		$	116,725,000
Accumulated deficit		(11,033,028	)		(1,725,000	)		(12,758,028	)
Total stockholders' deficit		(11,032,715	)		(1,725,000	)		(12,757,715	)

	March 31, 2021
	As Previously Reported in Amendment No. 1 of September 30, 2021 Form 10-Q			Adjustments			As Revised
Balance Sheet (unaudited)
Common stock subject to redemption	$	115,000,000		$	1,725,000		$	116,725,000
Accumulated deficit		(9,447,967	)		(1,725,000	)		(11,172,967	)
Total stockholders' deficit		(9,447,654	)		(1,725,000	)		(11,172,654	)

	December 31, 2020
	As Previously Reported			Adjustments			As Revised
Balance Sheet (audited)
Common stock subject to redemption	$	115,000,000		$	1,725,000		$	116,725,000
Accumulated deficit		(15,224,285	)		(1,725,000	)		(16,949,285	)
Total stockholders' deficit		(15,223,972	)		(1,725,000	)		(16,948,972	)

Changes in the Statement of Cash Flows for the Year Ended December 31, 2021

	December 31, 2021
	As Previously Reported		Adjustments		As Revised		Change
Statement of Cash Flows (audited)
Supplemental disclosure of non-cash financing activities:
Accretion of Common Stock to redemption value	$	—	$	(1,150,000)	$	(1,150,000)	100%

Changes in the Statement of Cash Flows for the Year Ended December 31, 2020

	December 31, 2020
	As Previously Reported		Adjustments		As Revised		Change
Statement of Cash Flows (audited)
Supplemental disclosure of non-cash financing activities:
Accretion of Common Stock to redemption value	$	(18,499,250)	$	(1,725,000)	$	(20,224,250)	9%